Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StockNews.com 

Phibro Animal Health Corp. A diskutieren

Phibro Animal Health Corp. A

WKN: A1WZ6P / Symbol: PAHC / Name: Phibro Animl / Aktie / Pharmazeutika / Small Cap /

34,20 €
0,59 %

Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PAHC provided by MarketBeat

Einschätzung Buy
Rendite (%) 43,28 %
Kursziel 19,44
Veränderung
Endet am 29.08.24

Phibro Animal Health Co. (NASDAQ: PAHC) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $21.00 price target on the stock.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PAHC provided by MarketBeat

Einschätzung Sell
Rendite (%) 115,84 %
Kursziel 8,34
Veränderung
Endet am 07.12.24

Phibro Animal Health Co. (NASDAQ: PAHC) is now covered by analysts at BNP Paribas. They set an "underperform" rating and a $9.00 price target on the stock.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PAHC provided by MarketBeat

Einschätzung Sell
Rendite (%) 24,22 %
Kursziel 12,06
Veränderung
Endet am 10.05.25

Phibro Animal Health Co. (NASDAQ: PAHC) had its price target raised by analysts at Barclays PLC from $10.00 to $13.00. They now have an "underweight" rating on the stock.
Ratings data for PAHC provided by MarketBeat

Einschätzung Sell
Rendite (%) 62,96 %
Kursziel 13,55
Veränderung
Endet am 30.08.25

Phibro Animal Health Co. (NASDAQ: PAHC) had its price target raised by analysts at Bank of America Co. from $13.00 to $15.00. They now have an "underperform" rating on the stock.
Ratings data for PAHC provided by MarketBeat

Einschätzung Sell
Rendite (%) 64,10 %
Kursziel 18,86
Veränderung
Endet am 12.11.25

Phibro Animal Health Co. (NASDAQ: PAHC) had its price target raised by analysts at Barclays PLC from $13.00 to $20.00. They now have an "underweight" rating on the stock.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for PAHC provided by MarketBeat

Einschätzung Sell
Rendite (%) 36,00 %
Kursziel 21,31
Veränderung
Endet am 10.02.26

Phibro Animal Health Co. (NASDAQ: PAHC) had its price target raised by analysts at Barclays PLC from $20.00 to $22.00. They now have an "underweight" rating on the stock.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PAHC provided by MarketBeat

Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PAHC provided by MarketBeat

Einschätzung Buy
Rendite (%) 33,49 %
Kursziel 29,73
Veränderung
Endet am 07.07.26

Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Ratings data for PAHC provided by MarketBeat

Einschätzung Sell
Rendite (%) 10,52 %
Kursziel 23,16
Veränderung
Endet am 29.08.26

Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at Bank of America Corporation from $19.00 to $27.00. They now have an "underperform" rating on the stock.
Ratings data for PAHC provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,67 %
Kursziel 43,34
Veränderung
Endet am 07.11.26

Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for PAHC provided by MarketBeat